Global Electroceuticals Market Size is valued at USD 26.04 billion in 2025 and is predicted to reach USD 53.05 billion by the year 2035 at a 7.5% CAGR during the forecast period for 2026 to 2035. Electroceuticals Market Size, Share & Trends Analysis Report, By Product (Cardiac Pacemakers & Implantable Cardioverter Defibrillators, Cochlear Implants, Neuromodulators, Retinal Implants), By Type (Implantable Electroceutical Devices and ...
Report ID: 1764 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 180
The Parkinson’s Disease Therapeutic Market Size is valued at USD 5.22 billion in 2025 and is predicted to reach USD 9.46 billion by the year 2035 at a 6.5% CAGR during the forecast period for 2026 to 2035. Parkinson's Disease Therapeutic Market Size, Share & Trends Analysis Report By Drugs (Carbidopa-levodopa, Dopamine agonists, Mao-b inhibitors, COMT inhibitors, Anticholinergics), By Distribution Channel (Hospital pharmacy, Retai...
Report ID: 2587 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 170
Ocular Inflammation Treatment Market Size is valued at USD 487.01 Mn in 2025 and is predicted to reach USD 914.17 Mn by the year 2035 at a 6.9% CAGR during the forecast period for 2026 to 2035. Ocular Inflammation Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Corticosteroids, Antibiotics, Monoclonal Antibodies, Immunosppressant, Cycloplegic Agents, Antivirals, Antifungal, Analgesics), By Disease Type, By ...
Report ID: 2407 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 180
Global Cell Line Characterization Market Size is valued at USD 432.23 Mn in 2025 and is predicted to reach USD 922.37 Mn by the year 2035 at an 8.0% CAGR during the forecast period for 2026 to 2035. Cell Line Characterization Market Size, Share & Trends Analysis Distribution by Application (Cell Line Identity, Genetic Stability, Viral and Microbial Contamination), End User (Pharmaceutical and Biotechnology Companies, Academic and Research In...
Report ID: 2668 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 165
Global Non surgical Skin Tightening Market Size is valued at US$ 3.6 Bn in 2025 and is predicted to reach US$ 12.8 Bn by the year 2035 at an 13.7% CAGR during the forecast period for 2026 to 2035. Non Surgical Skin Tightening Market Size, Share & Trends Analysis Distribution by Type of Treatment (Infrared Therapy (Ultrasound Therapy (Focused Ultrasound, Micro-focused Ultrasound), Laser Therapy (Fractional Laser, Non-ablative Laser)...
Report ID: 3233 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 180
Peptide Drug Discovery Market Size is valued at 810.85 Mn in 2025 and is predicted to reach 2,481.57 Mn by the year 2035 at an 12.2% CAGR during the forecast period for 2026 to 2035. Peptide Drug Discovery Market Size, Share & Trends Analysis Distribution By Type Of Product (Synthetic Peptides, Biological And Recombinant Peptides And Macrocycles), Drug Discovery Steps (Target Identification And Validation, Hit Identification, ...
Report ID: 2510 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 180
Global Nasal Vaccines Market is valued at USD 492.77 Million in 2025 and is predicted to reach USD 1,201.41 Million by the year 2035 at 9.7% CAGR during the forecast period for 2026 to 2035. Nasal Vaccines Market Size, Share & Trends Analysis Report By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit, Recombinant, and Conjugate Vaccines), By Application (Influenza, COVID-19), By Region, And By Segment Forecasts, 202...
Report ID: 2937 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 180
Global Psoriasis Biosimilars Market Size is valued at USD 8.5 billion in 2023 and is predicted to reach USD 19.3 billion by the year 2031 at a 10.9% CAGR during the forecast period for 2024 to 2031. Psoriasis Biosimilars Market Size, Share & Trends Analysis Report By Drug Class (TNF-alpha inhibitors (Infliximab, Etanercept, Adalimumab), Other biosimilars), By Route of Administration (Subcutaneous, Intravenous, Oral, Topical), By Indication (...
Report ID: 2891 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 160
Global Thyroid Eye Disease Market Size is valued at USD 2.26 billion in 2024 and is predicted to reach USD 4.02 billion by the year 2034 at a 6.0% CAGR during the forecast period for 2025 to 2034. Thyroid Eye Disease Market Size, Share & Trends Analysis Report By Marketed Treatment (TEPEZZA (Teprotumumab), By Pipeline Treatment (VRDN 001, VB 421, Batoclimab, Linsitnib), By Region, And By Segment Forecasts, 2026 to 2035 Thyroid Eye Disease...
Report ID: 2893 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 172
Global Autosomal Dominant Hypocalcemia Type 1 Market Size is predicted to grow at a 2.96% CAGR during the forecast period for 2024 to 2031. Autosomal Dominant Hypocalcemia Type 1 Market Size, Share & Trends Analysis Report By Treatment (Calcium Analogs, Vitamin Analogs), By End-User (Hospitals, Clinics, Others), By Region, And By Segment Forecasts, 2026 to 2035 Autosomal dominant hypocalcemia type 1 (ADH1) is a rare inherited condition ch...
Report ID: 2894 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 165
Pharmaceuticals